mdr k pneumoniae strains Search Results


mdr k pneumoniae strains  (ATCC)
99
ATCC mdr k pneumoniae strains
MICs of K. <t> pneumoniae </t> isolates.
Mdr K Pneumoniae Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mdr k pneumoniae strains/product/ATCC
Average 99 stars, based on 1 article reviews
mdr k pneumoniae strains - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
mdr k pneumoniae strain  (ATCC)
94
ATCC mdr k pneumoniae strain
(A and B) Checkerboard assays showed sensitization of A. baumannii by MD-124 towards rifampicin and novobiocin. (C and D) Checkerboard assays showed sensitization of K. <t>pneumoniae</t> by MD-124 towards rifampicin and clarithromycin. (E) Sensitization of an NDM-1-expressing strain of E. coli by MD-124 towards rifampicin. (F) Sensitization of an mcr-1-expressing strain of E. coli by MD-124 towards rifampicin. (G) Sensitization of <t>MDR</t> K. pneumoniae by MD-124 towards rifampicin. (H) Sensitization of MDR S. Typhimurium by MD-124 towards rifampicin. All experiments were done at least in biologically independent duplicate.
Mdr K Pneumoniae Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mdr k pneumoniae strain/product/ATCC
Average 94 stars, based on 1 article reviews
mdr k pneumoniae strain - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


MICs of K. pneumoniae isolates.

Journal: Frontiers in Pharmacology

Article Title: In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae

doi: 10.3389/fphar.2022.880352

Figure Lengend Snippet: MICs of K. pneumoniae isolates.

Article Snippet: With the aim of identifying promising metabolite adjuvants to increase antimicrobial activity of polymyxin B against K. pneumoniae , we have studied polymyxin-resistant strain ATCC 10031, polymyxin-susceptible strain ATCC 700721, and polymyxin-susceptible but MDR K. pneumoniae strains (ATCC 700603 and BAA-2146) ( ) .

Techniques:

(A and B) Checkerboard assays showed sensitization of A. baumannii by MD-124 towards rifampicin and novobiocin. (C and D) Checkerboard assays showed sensitization of K. pneumoniae by MD-124 towards rifampicin and clarithromycin. (E) Sensitization of an NDM-1-expressing strain of E. coli by MD-124 towards rifampicin. (F) Sensitization of an mcr-1-expressing strain of E. coli by MD-124 towards rifampicin. (G) Sensitization of MDR K. pneumoniae by MD-124 towards rifampicin. (H) Sensitization of MDR S. Typhimurium by MD-124 towards rifampicin. All experiments were done at least in biologically independent duplicate.

Journal: ACS infectious diseases

Article Title: Restoring and enhancing the potency of existing antibiotics against drug-resistant Gram-negative bacteria through the development of potent small-molecule adjuvants

doi: 10.1021/acsinfecdis.2c00121

Figure Lengend Snippet: (A and B) Checkerboard assays showed sensitization of A. baumannii by MD-124 towards rifampicin and novobiocin. (C and D) Checkerboard assays showed sensitization of K. pneumoniae by MD-124 towards rifampicin and clarithromycin. (E) Sensitization of an NDM-1-expressing strain of E. coli by MD-124 towards rifampicin. (F) Sensitization of an mcr-1-expressing strain of E. coli by MD-124 towards rifampicin. (G) Sensitization of MDR K. pneumoniae by MD-124 towards rifampicin. (H) Sensitization of MDR S. Typhimurium by MD-124 towards rifampicin. All experiments were done at least in biologically independent duplicate.

Article Snippet: Thus, MD-124 was tested on one MDR K. pneumoniae strain (ATCC BAA-2472) and one MDR S. Typhimurium strain (ATCC 14028), both of which are resistant to almost all antibiotics.

Techniques: Expressing